Cargando…

An Innovative Cascade System for Simultaneous Separation of Multiple Cell Types

Isolation of different cell types from one sample by fluorescence activated cell sorting is standard but expensive and time consuming. Magnetic separation is more cost effective and faster by but requires substantial effort. An innovative pluriBead-cascade cell isolation system (pluriSelect GmbH, Le...

Descripción completa

Detalles Bibliográficos
Autores principales: Pierzchalski, Arkadiusz, Mittag, Anja, Bocsi, Jozsef, Tarnok, Attila
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3765397/
https://www.ncbi.nlm.nih.gov/pubmed/24040334
http://dx.doi.org/10.1371/journal.pone.0074745
_version_ 1782283299707682816
author Pierzchalski, Arkadiusz
Mittag, Anja
Bocsi, Jozsef
Tarnok, Attila
author_facet Pierzchalski, Arkadiusz
Mittag, Anja
Bocsi, Jozsef
Tarnok, Attila
author_sort Pierzchalski, Arkadiusz
collection PubMed
description Isolation of different cell types from one sample by fluorescence activated cell sorting is standard but expensive and time consuming. Magnetic separation is more cost effective and faster by but requires substantial effort. An innovative pluriBead-cascade cell isolation system (pluriSelect GmbH, Leipzig, Germany) simultaneously separates two or more different cell types. It is based on antibody-mediated binding of cells to beads of different size and their isolation with sieves of different mesh-size. For the first time, we validated the pluriSelect system for simultaneous separation of CD4+- and CD8+-cells from human EDTA-blood samples. Results were compared with those obtained by magnetic activated cell sorting (MACS; two steps -first isolation of CD4+, then restaining of the residual cell suspension with anti-human CD8+ MACS antibody followed by the second isolation). pluriSelect separation was done in whole blood, MACS separation on density gradient isolated mononuclear cells. Isolated and residual cells were immunophenotyped by 7-color 9-marker panel (CD3; CD16/56; CD4; CD8; CD14; CD19; CD45; HLA-DR) using flow cytometry. Cell count, purity, yield and viability (7-AAD exclusion) were determined. There were no significant differences between both systems regarding purity (MACS (median[range]: 92.4% [91.5-94.9] vs. pluriSelect 95% [94.9-96.8])) of CD4+ cells, however CD8+ isolation showed lower purity by MACS (74.8% [67.6-77.9], pluriSelect 89.9% [89.0-95.7]). Yield was not significantly different for CD4 (MACS 58.5% [54.1-67.5], pluriSelect 67.9% [56.8-69.8]) and for CD8 (MACS 57.2% [41.3-72.0], pluriSelect 67.2% [60.0-78.5]). Viability was slightly higher with MACS for CD4+ (98.4% [97.8-99.0], pluriSelect 94.1% [92.1-95.2]) and for CD8+-cells (98.8% [98.3-99.1], pluriSelect 86.7% [84.2-89.9]). pluriSelect separation was substantially faster than MACS (1h vs. 2.5h) and no pre-enrichment steps were necessary. In conclusion, pluriSelect is a fast, simple and gentle system for efficient simultaneous separation of two and more cell subpopulation directly from whole blood and provides a simple alternative to magnetic separation.
format Online
Article
Text
id pubmed-3765397
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-37653972013-09-13 An Innovative Cascade System for Simultaneous Separation of Multiple Cell Types Pierzchalski, Arkadiusz Mittag, Anja Bocsi, Jozsef Tarnok, Attila PLoS One Research Article Isolation of different cell types from one sample by fluorescence activated cell sorting is standard but expensive and time consuming. Magnetic separation is more cost effective and faster by but requires substantial effort. An innovative pluriBead-cascade cell isolation system (pluriSelect GmbH, Leipzig, Germany) simultaneously separates two or more different cell types. It is based on antibody-mediated binding of cells to beads of different size and their isolation with sieves of different mesh-size. For the first time, we validated the pluriSelect system for simultaneous separation of CD4+- and CD8+-cells from human EDTA-blood samples. Results were compared with those obtained by magnetic activated cell sorting (MACS; two steps -first isolation of CD4+, then restaining of the residual cell suspension with anti-human CD8+ MACS antibody followed by the second isolation). pluriSelect separation was done in whole blood, MACS separation on density gradient isolated mononuclear cells. Isolated and residual cells were immunophenotyped by 7-color 9-marker panel (CD3; CD16/56; CD4; CD8; CD14; CD19; CD45; HLA-DR) using flow cytometry. Cell count, purity, yield and viability (7-AAD exclusion) were determined. There were no significant differences between both systems regarding purity (MACS (median[range]: 92.4% [91.5-94.9] vs. pluriSelect 95% [94.9-96.8])) of CD4+ cells, however CD8+ isolation showed lower purity by MACS (74.8% [67.6-77.9], pluriSelect 89.9% [89.0-95.7]). Yield was not significantly different for CD4 (MACS 58.5% [54.1-67.5], pluriSelect 67.9% [56.8-69.8]) and for CD8 (MACS 57.2% [41.3-72.0], pluriSelect 67.2% [60.0-78.5]). Viability was slightly higher with MACS for CD4+ (98.4% [97.8-99.0], pluriSelect 94.1% [92.1-95.2]) and for CD8+-cells (98.8% [98.3-99.1], pluriSelect 86.7% [84.2-89.9]). pluriSelect separation was substantially faster than MACS (1h vs. 2.5h) and no pre-enrichment steps were necessary. In conclusion, pluriSelect is a fast, simple and gentle system for efficient simultaneous separation of two and more cell subpopulation directly from whole blood and provides a simple alternative to magnetic separation. Public Library of Science 2013-09-06 /pmc/articles/PMC3765397/ /pubmed/24040334 http://dx.doi.org/10.1371/journal.pone.0074745 Text en © 2013 Pierzchalski et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Pierzchalski, Arkadiusz
Mittag, Anja
Bocsi, Jozsef
Tarnok, Attila
An Innovative Cascade System for Simultaneous Separation of Multiple Cell Types
title An Innovative Cascade System for Simultaneous Separation of Multiple Cell Types
title_full An Innovative Cascade System for Simultaneous Separation of Multiple Cell Types
title_fullStr An Innovative Cascade System for Simultaneous Separation of Multiple Cell Types
title_full_unstemmed An Innovative Cascade System for Simultaneous Separation of Multiple Cell Types
title_short An Innovative Cascade System for Simultaneous Separation of Multiple Cell Types
title_sort innovative cascade system for simultaneous separation of multiple cell types
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3765397/
https://www.ncbi.nlm.nih.gov/pubmed/24040334
http://dx.doi.org/10.1371/journal.pone.0074745
work_keys_str_mv AT pierzchalskiarkadiusz aninnovativecascadesystemforsimultaneousseparationofmultiplecelltypes
AT mittaganja aninnovativecascadesystemforsimultaneousseparationofmultiplecelltypes
AT bocsijozsef aninnovativecascadesystemforsimultaneousseparationofmultiplecelltypes
AT tarnokattila aninnovativecascadesystemforsimultaneousseparationofmultiplecelltypes
AT pierzchalskiarkadiusz innovativecascadesystemforsimultaneousseparationofmultiplecelltypes
AT mittaganja innovativecascadesystemforsimultaneousseparationofmultiplecelltypes
AT bocsijozsef innovativecascadesystemforsimultaneousseparationofmultiplecelltypes
AT tarnokattila innovativecascadesystemforsimultaneousseparationofmultiplecelltypes